Clearmind MedicineCMND
13F holders, Q3 2025 (September 30)7holders −2
2new positions
4sold out
$1.03avg. 13F price*
At the end of Q3 2025, 7 institutions reported holding Clearmind Medicine Inc. (CMND) in their 13F filings, down 2 from Q2 2025. 2 opened new positions and 4 sold out. The largest holders were AdvisorShares Investments LLC ($230K), Virtu Financial LLC ($29K) and Susquehanna International Group, LLP ($25K).
- Company
- Clearmind Medicine Inc.
- CUSIP
- 185053402
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $54K |
| Exits | 4 | $5.3M |
All 13F filers, Q2 2025 → Q3 2025: 71,291 shares bought and 379,580 shares sold, net −308,289 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 7 holders
| AdvisorShares Investments LLC | 0.04% | Add +9.0% | 224,378 | $230K |
| Virtu Financial LLC | 0.00% | New | 28,554 | $29K |
| Susquehanna International Group, LLP | 0.00% | New | 24,292 | $25K |
| Morgan Stanley | 0.00% | No change | 2,564 | $3K |
| Royal Bank of Canada | 0.00% | No change | 569 | $1K |
| Osaic Holdings, Inc. | 0.00% | No change | 395 | $404 |
| National Bank of Canada | 0.00% | No change | 379 | $387 |
"% of holder's portfolio" is CMND's weight in each manager's 13F, not the share of Clearmind Medicine Inc. the manager owns.